AmerisourceBergen Corporation

150.50+2.74+1.85%Vol 854.33K1Y Perf 23.48%
Aug 12th, 2022 16:00 DELAYED
BID143.06 ASK158.66
Open148.16 Previous Close147.76
Pre-Market- After-Market150.57
 - -  0.07 0.05%
Target Price
170.00 
Analyst Rating
Moderate Buy 1.80
Potential %
12.96 
Finscreener Ranking
+     38.71
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
     38.75
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★     44.79
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
+     26.37
Price Range Ratio 52W %
68.81 
Earnings Rating
Neutral
Market Cap31.19B 
Earnings Date
3rd Aug 2022
Alpha0.01 Standard Deviation0.07
Beta0.49 

Today's Price Range

147.77150.62

52W Range

113.68167.19

5 Year PE Ratio Range

-5.5064.80

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
6.50%
1 Month
8.19%
3 Months
-1.56%
6 Months
7.32%
1 Year
23.48%
3 Years
68.61%
5 Years
88.08%
10 Years
309.64%

TickerPriceChg.Chg.%
ABC150.502.74001.85
AAPL172.123.63002.15
GOOG122.652.83002.36
MSFT291.914.89001.70
XOM94.000.81000.87
WFC45.940.69001.52
JNJ165.30-1.8400-1.10
FB196.640.99000.51
GE79.931.03001.31
JPM122.131.99001.66
 
ProfitabilityValueIndustryS&P 500US Markets
3.60
1.10
1.40
0.00
0.76
RevenueValueIndustryS&P 500US Markets
236.33B
1.14K
7.72
7.84
DividendsValueIndustryS&P 500US Markets
1.24
1.84
4.05
4.46
Payout ratio21.00
Earnings HistoryEstimateReportedSurprise %
Q03 20222.572.621.95
Q02 20222.993.227.69
Q01 20222.592.58-0.39
Q04 20212.362.391.27
Q03 20212.012.167.46
Q02 20212.512.530.80
Q01 20211.942.1812.37
Q04 20201.871.891.07
Earnings Per EndEstimateRevision %Trend
6/2022 QR2.57-0.77Negative
9/2022 QR2.57-0.39Negative
9/2022 FY10.951.67Positive
9/2023 FY11.45-0.95Negative
Next Report Date-
Estimated EPS Next Report2.57
Estimates Count7
EPS Growth Next 5 Years %8.10
Volume Overview
Volume854.33K
Shares Outstanding207.26K
Shares Float150.08M
Trades Count19.26K
Dollar Volume127.80M
Avg. Volume1.12M
Avg. Weekly Volume1.06M
Avg. Monthly Volume971.00K
Avg. Quarterly Volume1.32M

AmerisourceBergen Corporation (NYSE: ABC) stock closed at 150.5 per share at the end of the most recent trading day (a 1.85% change compared to the prior day closing price) with a volume of 854.33K shares and market capitalization of 31.19B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Distribution industry, Healthcare sector and employs 22000 people. AmerisourceBergen Corporation CEO is Steven H. Collis.

The one-year performance of AmerisourceBergen Corporation stock is 23.48%, while year-to-date (YTD) performance is 13.25%. ABC stock has a five-year performance of 88.08%. Its 52-week range is between 113.68 and 167.19, which gives ABC stock a 52-week price range ratio of 68.81%

AmerisourceBergen Corporation currently has a PE ratio of 17.00, a price-to-book (PB) ratio of 136.96, a price-to-sale (PS) ratio of 0.13, a price to cashflow ratio of 12.30, a PEG ratio of 2.32, a ROA of 3.46%, a ROC of 29.87% and a ROE of 1 428.59%. The company’s profit margin is 0.76%, its EBITDA margin is 1.40%, and its revenue ttm is $236.33 Billion , which makes it $1 140.25 revenue per share.

Of the last four earnings reports from AmerisourceBergen Corporation, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $2.57 for the next earnings report. AmerisourceBergen Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for AmerisourceBergen Corporation is Moderate Buy (1.8), with a target price of $170, which is +12.96% compared to the current price. The earnings rating for AmerisourceBergen Corporation stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

AmerisourceBergen Corporation has a dividend yield of 1.24% with a dividend per share of $1.84 and a payout ratio of 21.00%.

AmerisourceBergen Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 8.73, ATR14 : 3.55, CCI20 : 196.92, Chaikin Money Flow : 0.04, MACD : 0.86, Money Flow Index : 64.05, ROC : 3.74, RSI : 66.42, STOCH (14,3) : 99.11, STOCH RSI : 1.00, UO : 54.70, Williams %R : -0.89), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of AmerisourceBergen Corporation in the last 12-months were: Dermot Mark Durcan (Option Excercise at a value of $0), Elizabeth S. Campbell (Option Excercise at a value of $1 143 244), Elizabeth S. Campbell (Sold 14 034 shares of value $1 935 148 ), Gina K. Clark (Option Excercise at a value of $3 806 499), Gina K. Clark (Sold 59 731 shares of value $8 734 421 ), James F. Cleary (Option Excercise at a value of $0), Jane E Henney (Option Excercise at a value of $0), John G. Chou (Option Excercise at a value of $539 446), John G. Chou (Sold 6 081 shares of value $717 193 ), Kathleen W. Hyle (Option Excercise at a value of $0), Lazarus Krikorian (Option Excercise at a value of $3 235 717), Lazarus Krikorian (Sold 40 980 shares of value $5 665 601 ), Leslie E. Donato (Option Excercise at a value of $0), Lon R. Greenberg (Option Excercise at a value of $0), Michael J. Long (Option Excercise at a value of $0), Richard W. Gochnauer (Option Excercise at a value of $0), Robert P. Mauch (Option Excercise at a value of $7 498 327), Robert P. Mauch (Sold 85 706 shares of value $11 262 946 ), Silvana Battaglia (Option Excercise at a value of $0), Silvana Battaglia (Sold 6 820 shares of value $1 022 727 ), Steven H. Collis (Option Excercise at a value of $19 207 386), Steven H. Collis (Sold 273 249 shares of value $36 145 796 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (60.00 %)
5 (55.56 %)
2 (33.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
4 (40.00 %)
4 (44.44 %)
4 (66.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.80
Moderate Buy
1.89
Moderate Buy
2.33

AmerisourceBergen Corporation

AmerisourceBergen is a leading pharmaceutical wholesaler engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospital networks, and healthcare providers. Along with McKesson and Cardinal Health, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Through bolt-on acquisitions, the company has expanded into international wholesale in Europe (Alliance Healthcare) and South America (Profarma). AmerisourceBergen provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health).

CEO: Steven H. Collis

Telephone: +1 610 727-7000

Address: 1300 Morris Drive, Chesterbrook 19087-5594, PA, US

Number of employees: 22 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

63%38%

TipRanks News for ABC

Wed, 27 Jul 2022 09:29 GMT AmerisourceBergen (ABC) Receives a Buy from Deutsche Bank

- TipRanks. All rights reserved.

Wed, 29 Jun 2022 18:00 GMT BRAD MOSES NAMED THE NEW GENERAL MANAGER OF WTVG (ABC) IN TOLEDO, OHIO

- TipRanks. All rights reserved.

Fri, 03 Jun 2022 03:15 GMT Analysts Offer Insights on Healthcare Companies: AmerisourceBergen (ABC), Amgen (AMGN) and BioMarin Pharmaceutical (BMRN)

- TipRanks. All rights reserved.

Wed, 25 May 2022 04:25 GMT Analysts Offer Insights on Healthcare Companies: AmerisourceBergen (ABC), Prothena (PRTA) and Pharvaris (PHVS)

- TipRanks. All rights reserved.

Mon, 25 Apr 2022 13:14 GMT AmerisourceBergen (ABC) Receives a Hold from Deutsche Bank

- TipRanks. All rights reserved.

News

Stocktwits